Yili Peptide Tirzepatide catalogue presentation
Catalogue illustration · confirm the selected presentation

WHOLESALE PRODUCT SPECIFICATIONS

Tirzepatide

Lyophilized powder. White to off-white lyophilized powder. Compare presentations and review the available product documents before requesting a quote.

10 sealed vials per kitLaboratory research use only
Tirzepatide catalogue specifications and document links
CodePresentationDocuments
TR1010 mg x 10 vialsRequest
TR1515 mg x 10 vialsRequest
TR2020 mg x 10 vialsRequest
TR3030 mg x 10 vialsRequest
TR4040 mg x 10 vialsRequest
TR6060 mg x 10 vialsRequest

TR15 identifies the Tirzepatide 15 mg x 10 vials catalog presentation.

BATCH DOCUMENTATION

Tirzepatide batch COAs.

Open the COA Library ↗

Request the COA matching your selected presentation and batch. Earlier submitted-sample reports and raw-material COAs, where available below, retain their own document scope.

No batch-linked finished-vial COA is currently published for this product.

Request the applicable document ↗

Additional source documents

These records retain their own sample or source-material scope and do not replace a matching batch COA.

Earlier finished-vial sample reports1 record

Tirzepatide · TR20

TR20-20260917S8803 ·

Reported purity 99.79%, detected mass spectrum and net content 21.06 mg.

Applies only to the submitted TR20 vial sample. The report states that it is not CMA/CNAS certification and is not a legal certification document.

Open source PDF ↗
Raw-material COAs1 record

Tirzepatide · Bulk raw material

024-T85-TSX ·

Vendor-issued raw-material COA reporting 99.03% HPLC purity and 93.9% peptide content.

Bulk source-material record only. It does not verify the finished TR20 sample or a future production lot.

Open source PDF ↗

PRODUCT INFORMATION

Identity, presentation and handling.

Catalogue reference data

Form
Lyophilized powder
Appearance
White to off-white lyophilized powder.
CAS No.
2023788-19-2
Sequence
Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(AEEA-AEEA-gamma-Glu-eicosanedioic acid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2.
Packaging
10 sealed vials per kit
Intended use
Laboratory research use only

Storage & handling

Lyophilized material
Store at -20°C in a tightly sealed vial, protected from light and moisture. Allow the sealed vial to reach room temperature before opening.
After reconstitution
For short-term laboratory handling, keep at 2-8°C. For longer storage, aliquot and freeze at <=-20°C when the experimental buffer is compatible. Avoid repeated freeze-thaw cycles.
Read the storage and temperature guide ↗

WHOLESALE SOURCING

Build the Tirzepatide request around one exact TR code.

Yili lists six Tirzepatide presentations. The public TR20 finished-vial report applies only to its submitted sample; the bulk raw-material COA remains a separate evidence class.

Choose TR10, TR15, TR20, TR30, TR40 or TR60 and the number of ten-vial kits. A TR20 result does not establish the quality of another strength or future production lot.

  1. 01

    Define the wholesale presentation

    State the TR code, first-order or repeat-order quantity and destination so availability can be checked against a real request.

  2. 02

    Match the record to its sample

    Review TR20 and the raw-material document by their own identifiers and analytical scope.

  3. 03

    Add order-linked presentation

    Include label, carton, cap and document-link requirements only after the product and kit quantity are fixed.

Request a specification-led quote.

Include the code, quantity, destination and batch or document number you want to review.

Prepare Tirzepatide inquiry